Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients

Singapore Medical Journal

Volumn 53, Issue 9, 2012, Pages 615-619

  Moghadam, Ali Malekshahi ^a   Saedisomeolia, Ahmad ^b   Djalali, Mahmoud ^b   Djazayery, Abolghasem ^b   Pooya, Shabnam ^b   Sojoudi, Fereshteh ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CRP; Diabetes mellitus type 2; IL 2; Omega 3 fatty acid; TNF

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 2; OMEGA 3 FATTY ACID; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-2; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870040658     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ramel A, Martinéz A, Kiely M, et al. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008; 51:1261-1268.
2. Brunner E.J, Kivimäki M, Witte D.R, et al. Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream. PLoS Med 2008; 5:e155.
3. Pooya S, Jalali M.D, Jazayery A.D, et al. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2010; 20:326-331.
4. Gómez J.M, Vila R, Catalina P, et al. The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives. Glycoconj J 2008; 25:573-579.
5. Yaturu S, Rains J, Jain S.K. Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. Cytokine 2008; 44:168-171.
6. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21:495-505.
7. Mori T.A, Beilin L.J. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 2004; 6:461-467.
8. Martin R.E. Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res 1998; 54:805-813.
9. Kang J.X, Man S.F, Brown N.E, et al. Essential fatty acid metabolism in cultured human airway epithelial cells. Biochim Biophys Acta 1992; 1128:267-274.
10. Lee J.Y, Zhao L, Youn H.S, et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004; 279:16971-1699.
11. Horia E, Watkins B.A. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells. Carcinogenesis 2007; 28:809-815.
12. Saedisomeolia A, Wood L.G, Garg M.L, Gibson P.G, Wark P.A. Antiinflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells. Br J Nutr 2009; 101:533-540.
13. Marik P.E, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009; 32:365-372.
14. Freund-Levi Y, Hjorth E, Lindberg C, et al. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord 2009; 27:481-490.
15. Suresh Y, Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. Nutrition 2003; 19:213-228.
16. Pischon T, Hankinson S.E, Hotamisligil G.S, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108:155-160.
17. Tsitouras P.D, Gucciardo F, Salbe A.D, Heward C, Harman S.M. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 2008; 40:199-205.
18. Nettleton J.A, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 2005; 105:428-440.
19. Fedor D, Kelley D.S. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 2009; 12:138-146.
20. Hu F.B, Cho E, Rexrode K.M, Albert C.M, Manson J.E. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003; 107:1852-1857.
21. Yessoufou A, Soulaimann N, Merzouk S.A, et al. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes (Lond) 2006; 30:739-750.
22. Anand R.G, Alkadri M, Lavie C.J, Milani R.V. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev 2008; 28:92-98.
23. Jung U.J, Torrejon C, Tighe A.P, Deckelbaum R.J. n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr 2008; 87:2003S-2009S.
24. Endres S, Ghorbani R, Kelley V.E, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-271.
25. Bagga D, Wang L, Farias-Eisner R, Glapsy J.A, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003; 100:1751-1756.
26. Ferrucci L, Cherubini A, Bandinelli S, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91:439-446.
27. Das U.N. Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids? J Assoc Physicians India 2005; 53:623-627.
28. Das U.N. COX-2 inhibitors and metabolism of essential fatty acids. Med Sci Monit 2005; 11:RA233-RA237.
29. Alnajjar A, Chabane Sari D, Abuharfeil N, Hudaib M, Aburjai T. Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people. Prostaglandins Leukot Essent Fatty Acids 2006; 74:347-356.
30. Jolly C.A, Jiang Y.H, Chapkin R.S, McMurray D.N. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 1997; 127:37-43.
31. Weber P.C, Leaf A. Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. World Rev Nutr Diet 1991; 66:218-232.
32. Novak T.E, Babcock T.A, Jho D.H, Helton W.S, Espat NJ. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol 2003; 284:L84-L89.
33. Magee P, Pearson S, Allen J. The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumor necrosis factor (TNF)- alpha during murine skeletal muscle cell differentiation. Lipids Health Dis 2008; 7:24.
34. Jellema A, Plat J, Mensink R.P. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 2004; 34:766-773.
35. Klein-Platat C, Drai J, Oujaa M, Schlienger J.L, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and lowgrade inflammation in overweight adolescents. Am J Clin Nutr 2005; 82: 1178-1184.
36. Schubert R, Kitz R, Beermann C, et al. Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults. Nutrition 2007; 23:724-730.
37. Holm T, Berge R.K, Andreassen A.K, et al. Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients. Transplantation 2001; 72:7067-11.
38. Skuladottir I.H, Petursdottir D.H, Hardardottir I. The effects of omega-3 polyunsaturated fatty acids on TNF-alpha and IL-10 secretion by murine peritoneal cells in vitro. Lipids 2007; 42:699-706.
39. Mori T.A, Woodman R.J, Burke V, et al. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated- hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003; 35:772-781.
40. Chan D.C, Watts G.F, Barret P.H, Beilin L.J, Mori T.A. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 2002; 48:877-883.
41. Wigmore S.J, Plester C.E, Richardson R.A, Fearon K.C. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 1997; 75:106-109.
42. Fakhrzadeh H, Poorebrahim R, Shooshtarizadeh P, Raza M, Hosseini S. The effects of consumption of omega3 fatty acid-enriched eggs on insulin and CRP. Nutr Metab Cardiovasc Dis 2005; 15:329-330.